BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 1617832)

  • 21. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis.
    Rozic JG; Chakraborty C; Lala PK
    Int J Cancer; 2001 Aug; 93(4):497-506. PubMed ID: 11477553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma.
    Pulaski BA; Clements VK; Pipeling MR; Ostrand-Rosenberg S
    Cancer Immunol Immunother; 2000 Apr; 49(1):34-45. PubMed ID: 10782864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
    Naito K; Pellis NR; Kahan BD
    Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types.
    Papa MZ; Mulé JJ; Rosenberg SA
    Cancer Res; 1986 Oct; 46(10):4973-8. PubMed ID: 3489517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
    Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
    Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killer (NK) cell activity in mice with acute graft-versus-host reactions: characterization of a Thy-1+ NK-like cell with a broadened spectrum of lytic activity in the spleen and lymph nodes.
    MacDonald GC; Gartner JG
    Scand J Immunol; 1991 May; 33(5):553-65. PubMed ID: 1709518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the host natural killer cell population in mice during tumor development. 1. Kinetics and in vivo significance.
    Lala PK; Santer V; Libenson H; Parhar RS
    Cell Immunol; 1985 Jul; 93(2):250-64. PubMed ID: 4005957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo.
    Sun R; Wei H; Zhang J; Li A; Zhang W; Tian Z
    Neuroimmunomodulation; 2002-2003; 10(3):169-76. PubMed ID: 12481157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanoma.
    Safwat A; Aggerholm N; Roitt I; Overgaard J; Hokland M
    J Exp Ther Oncol; 2003; 3(4):161-8. PubMed ID: 14567287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy.
    Mulé JJ; Ettinghausen SE; Spiess PJ; Shu S; Rosenberg SA
    Cancer Res; 1986 Feb; 46(2):676-83. PubMed ID: 3484431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
    Mulé JJ; Yang J; Shu S; Rosenberg SA
    J Immunol; 1986 May; 136(10):3899-909. PubMed ID: 2871106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of therapeutic effect of interleukin-2 on spontaneous pulmonary metastases of Lewis lung carcinoma by killer helper factor associated with increased induction of killer activity.
    Fukuta K; Sone S; Kitahara M; Okada M; Ogura T
    Jpn J Cancer Res; 1989 Jun; 80(6):562-7. PubMed ID: 2503476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus-mediated expression of interleukin-12 induces natural killer cell activity and complements adenovirus-directed gp75 treatment of melanoma lung metastases.
    Hirschowitz EA; Crystal RG
    Am J Respir Cell Mol Biol; 1999 May; 20(5):935-41. PubMed ID: 10226063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model.
    Walser TC; Ma X; Kundu N; Dorsey R; Goloubeva O; Fulton AM
    J Immunother; 2007; 30(5):490-8. PubMed ID: 17589289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced inhibition of tumour growth and metastasis, and induction of antitumour immunity by IL-2-IgG2b fusion protein.
    Budagian V; Nanni P; Lollini PL; Musiani P; Di Carlo E; Bulanova E; Paus R; Bulfone-Paus S
    Scand J Immunol; 2002 May; 55(5):484-92. PubMed ID: 11975760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced anti-metastatic efficacy of IL-2 activated NK (A-NK) cells with novel benzothiazoles.
    Goldfarb RH; Kitson RP; Brunson KW; Yoshino K; Hirota N; Kirii Y; Kotera Y; Inoue Y; Ohashi M
    Anticancer Res; 1999; 19(3A):1663-7. PubMed ID: 10470098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of immunotherapy in aged leukemic mice.
    Dussault I; Miller SC
    Gerontology; 1995; 41(4):195-204. PubMed ID: 7557496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CC chemokine CK beta-11/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells.
    Braun SE; Chen K; Foster RG; Kim CH; Hromas R; Kaplan MH; Broxmeyer HE; Cornetta K
    J Immunol; 2000 Apr; 164(8):4025-31. PubMed ID: 10754294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity in a rat mammary adenocarcinoma: the effect of cyclooxygenase inhibitors and immunization against prostaglandin E2.
    Karmali RA; Marsh J
    Prostaglandins Leukot Med; 1985 Dec; 20(3):283-6. PubMed ID: 3937158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.